<DOC>
	<DOCNO>NCT02100631</DOCNO>
	<brief_summary>Demonstrate vaccine offer protection base antibody level older adult similar antibody level adult age 18-45 follow vaccination PXVX0200 .</brief_summary>
	<brief_title>A Study Live Oral Cholera Vaccine , PXVX200 Healthy Older Adults</brief_title>
	<detailed_description />
	<mesh_term>Cholera</mesh_term>
	<criteria>healthy men woman , age 46 64 year inclusive ; normal medical history physical examination Women must negative pregnancy test travel cholera endemic area previous 5 year ; abnormal stool pattern regular use laxative ; Currently active unstable undiagnosed medical condition current recent antibiotic use ; pregnancy nursing ; Previously receive licensed investigational cholera vaccine History cholera enterotoxigenic E. coli infection History GuillainBarr√© Syndrome Received plan receive license vaccine , except seasonal influenza Recipient bone marrow solid organ transplant Malignancy ( exclude nonmelanotic skin cancer ) lymphoproliferative disorder diagnose treat past 5 year Use systemic chemotherapy previous 5 year prior study immunosuppressive medical condition</criteria>
	<gender>All</gender>
	<minimum_age>46 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>